Male breast cancer (MBC) is a rare malignancy, and gender-specific treatment outcomes are currently lacking. The use of a large, multi-national surgical-outcomes database may provide a better understanding of treatment patterns and postoperative morbidity in men who undergo oncological breast surgery.
A retrospective cohort analysis was conducted between 2007 and 2016 using the American College of Surgeons National Surgical Quality Improvement Program database (NSQIP), examining MBC treatment patterns and postoperative complication rates. All men undergoing surgery for the treatment of invasive or in situ carcinoma of the breast were identified. Clinical characteristics, demographics, and surgical treatment options most frequently used for this population were described. In addition, the 30-day postoperative complication rates in the surgical treatment of male breast cancer were evaluated.
A total of 1773 MBC patients with a median age of 65 years (IQR 56–74 years) were included in this analysis. Mean body mass index (BMI) was 29.1 (IQR 25.4–33.8). In this study population, 177 (10.0%) had a diagnosis of in situ breast cancer, while the remaining 1596 (90.0%) had invasive disease. While most men underwent mastectomy, 282 (15.9%) had breast-conserving surgery. There were 74 (4.2%) patients who underwent immediate breast reconstruction. In addition, 118 (6.7%) patients elected to have a contralateral prophylactic mastectomy. Overall, the rate of morbidity was 4.6%, comprising mostly of wound complications (3.2%).
Analysis of this large, prospective multi-institutional cohort revealed that complication rates are low and comparable to reported rates in the female breast cancer population. What is also significant about this analysis is that the cohort demonstrated the importance of cosmetic considerations in MBC patients, as some men decide to undergo breast-conserving surgery or immediate breast reconstruction. Contralateral prophylactic mastectomy in the treatment of MBC is also performed.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
Anderson WF et al (2010) Male breast cancer: a population-based comparison with female breast cancer. J Clin Oncol 28(2):232–239
Society AC (2018) Cancer statistics. 2018. https://cancerstatisticscenter.cancer.org/?_ga=2.201757139.379664396.1518877569-. Accessed 2 March 2018
Fentiman I (2009) Male breast cancer: a review. Ecancermedicalscience 3:140
Giordano SH, Buzdar AU, Hortobagyi GN (2002) Breast cancer in men. Ann Intern Med 137(8):678–687
Li X et al (2017) Hormone receptor-positive breast cancer has a worse prognosis in male than in female patients. Clin Breast Cancer 17(5):356–366
Ruddy KJ, Winer EP (2013) Male breast cancer: risk factors, biology, diagnosis, treatment, and survivorship. Ann Oncol 24(6):1434–1443
Joshi MG et al (1996) Male breast carcinoma: an evaluation of prognostic factors contributing to a poorer outcome. Cancer 77(3):490–498
Rayson D et al (1998) Molecular markers in male breast carcinoma. Cancer 83(9):1947–1955
Nahleh ZA et al (2007) Male breast cancer in the veterans affairs population: a comparative analysis. Cancer 109(8):1471–1477
Andre S et al (2007) Male and female breast cancer—differences in DNA ploidy, p21 and p53 expression reinforce the possibility of distinct pathways of oncogenesis. Pathobiology 74(6):323–327
De los Santos JF, Buchholz TA (2000) Carcinoma of the male breast. Curr Treat Options Oncol 1(3):221–227
Zaenger D et al (2016) Is breast conserving therapy a safe modality for early-stage male breast cancer? Clin Breast Cancer 16(2):101–104
Cloyd JM, Hernandez-Boussard T, Wapnir IL (2013) Outcomes of partial mastectomy in male breast cancer patients: analysis of SEER, 1983–2009. Ann Surg Oncol 20(5):1545–1550
Boughey JC et al (2006) Comparative analysis of sentinel lymph node operation in male and female breast cancer patients. J Am Coll Surg 203(4):475–480
Flynn LW et al (2008) Sentinel lymph node biopsy is successful and accurate in male breast carcinoma. J Am Coll Surg 206(4):616–621
Gentilini O et al (2007) Sentinel lymph node biopsy in male patients with early breast cancer. Oncologist 12(5):512–515
Goss PE et al (1999) Male breast carcinoma: a review of 229 patients who presented to the Princess Margaret Hospital during 40 years: 1955–1996. Cancer 85(3):629–639
Stalsberg H et al (1993) Histologic types and hormone receptors in breast cancer in men: a population-based study in 282 United States men. Cancer Causes Control 4(2):143–151
Agrawal A et al (2007) Male breast cancer: a review of clinical management. Breast Cancer Res Treat 103(1):11–21
Gunhan-Bilgen I et al (2002) Male breast disease: clinical, mammographic, and ultrasonographic features. Eur J Radiol 43(3):246–255
Golshan M et al (2007) Breast conservation for male breast carcinoma. Breast 16(6):653–656
Fields EC et al (2013) Management of male breast cancer in the United States: a surveillance, epidemiology and end results analysis. Int J Radiat Oncol Biol Phys 87(4):747–752
Caglia P et al (1998) Carcinoma of the male breast: reconstructive technique. G Chir 19(8–9):358–362
Di Benedetto G, Pierangeli M, Bertani A (1998) Carcinoma of the male breast: an underestimated killer. Plast Reconstr Surg 102(3):696–700
Igun GO (2000) Rectus abdominis myocutaneous flap in reconstruction for advanced male breast cancer: case report. Cent Afr J Med 46(5):130–132
Schaverien MV, Scott JR, Doughty JC (2013) Male mastectomy: an oncoplastic solution to improve aesthetic appearance. J Plast Reconstr Aesthet Surg 66(12):1777–1779
Spear SL, Bowen DG (1998) Breast reconstruction in a male with a transverse rectus abdominis flap. Plast Reconstr Surg 102(5):1615–1617
Auvinen A, Curtis RE, Ron E (2002) Risk of subsequent cancer following breast cancer in men. J Natl Cancer Inst 94(17):1330–1332
Jemal A et al (2015) Temporal trends in and factors associated with contralateral prophylactic mastectomy among US men with breast cancer. JAMA Surg 150(12):1192–1194
Angarita FA et al (2018) Thirty-day postoperative morbidity and mortality in elderly women with breast cancer: an analysis of the NSQIP database. Breast Cancer Res Treat. https://doi.org/10.1007/s10549-018-4747-5
de Blacam C et al (2012) High body mass index and smoking predict morbidity in breast cancer surgery: a multivariate analysis of 26,988 patients from the national surgical quality improvement program database. Ann Surg 255(3):551–555
El-Tamer MB et al (2007) Morbidity and mortality following breast cancer surgery in women: national benchmarks for standards of care. Ann Surg 245(5):665–71
Conflict of interest
The authors declare that they have no conflict of interest.
This article does not contain any studies with human participants or animals performed by any of the authors.
Poster Presentation: Annual Scientific Meeting, American Society of Breast Surgeons, Orlando, Florida, USA, May 2–8 2018.
About this article
Cite this article
Elmi, M., Sequeira, S., Azin, A. et al. Evolving surgical treatment decisions for male breast cancer: an analysis of the National Surgical Quality Improvement Program (NSQIP) database. Breast Cancer Res Treat 171, 427–434 (2018). https://doi.org/10.1007/s10549-018-4830-y
- Male breast cancer
- National Surgical Quality Improvement Program
- Surgical management of cancer
- Male breast reconstruction
- Male breast-conserving surgery